NVAX NOVAVAX INC Management Changes 8-K Filing 2023 - CEO Succession Novavax, Inc. announced the appointment of John C. Jacobs as President and CEO, succeeding Stanley C. Erck, who will retire. Jacobs has extensive experience in the pharmaceutical industry and will receive a base salary of $700,000 and various benefits. Erck will continue to provide consulting services to the company.Get access to all SEC 8-K filings of the NOVAVAX INC